Radiation therapy is one of the three pillars of cancer treatment, alongside surgery and systemic therapy. At Guangzhou Concord Cancer Center (GCCC), the Department of Radiation Oncology has assembled a team that combines international training, academic research and day-to-day clinical precision.
The department covers the complete range of modern radiotherapy: three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic radiotherapy (SBRT/SRS), image-guided radiotherapy (IGRT), Gamma Knife radiosurgery and proton therapy. Treatment sites include head and neck tumours, central nervous system tumours, thoracic tumours, gastrointestinal and gynaecological tumours, urological tumours and paediatric tumours.
Among them are medical physicists who have led proton physics programmes in the United States, chief physicians who have treated tens of thousands of patients, and young specialists trained at leading Chinese cancer centres. Together they plan and verify every course of treatment.
Our Radiation Oncology Specialists
Dr. Pan Xixin
Resident Physician
Specialty: Radiotherapy for central nervous system tumours, thoracic tumours and paediatric tumours
A young physician in the Department of Radiation Oncology. He holds a Master's degree in Oncology from Sun Yat-sen University and completed his standardised residency training in radiation oncology at the Fifth Affiliated Hospital of Sun Yat-sen University. He is familiar with precision radiotherapy for malignant tumours and specialises in the radiotherapy of central nervous system tumours, thoracic tumours and paediatric tumours, with practical experience in the treatment of common malignancies.
Dr. Li Yan
Resident Physician
Specialty: Radiotherapy for paediatric tumours, central nervous system tumours, head and neck tumours and thoracic tumours
A young physician in the Department of Radiation Oncology. From July 2023 to June 2026 she completed her standardised residency training in radiation oncology at the Fifth Affiliated Hospital of Sun Yat-sen University. She is experienced in the radiotherapy of a wide range of malignant tumours, with particular strengths in central nervous system tumours (germinoma, brain glioma), head and neck tumours (nasopharyngeal carcinoma, oral cancer and others), thoracic tumours (lung cancer, oesophageal cancer, breast cancer, thymoma and thymic carcinoma), paediatric tumours and gynaecological tumours.
Dr. Lin Feng
Resident Physician
Specialty: Head and neck tumours, central nervous system tumours and digestive system tumours
A young physician in the Department of Radiation Oncology. He holds a Master's degree in Radiation Oncology from Southern Medical University and has published two papers as first author or corresponding author. He is familiar with the radiotherapy of various malignant tumours, specialising in head and neck tumours (nasopharyngeal carcinoma, laryngeal cancer, tongue cancer and others), central nervous system tumours (glioma, germinoma and others) and digestive system tumours (colorectal cancer, gastric cancer).
Dr. Zhang Jian
Resident Physician
Specialty: Radiotherapy for central nervous system tumours, head and neck tumours and paediatric tumours
A young physician in the Department of Radiation Oncology. He holds a Master's degree in Radiation Oncology and specialises in the radiotherapy of central nervous system tumours, head and neck tumours and paediatric tumours. He has completed further training in the Department of Radiation Oncology at the Cancer Hospital of the Chinese Academy of Medical Sciences and has published two SCI papers as first author.
Dr. Lu Hui
Attending Physician
Specialty: Radiotherapy for central nervous system tumours, head and neck tumours, thoracic tumours and paediatric tumours
A young physician in the Department of Radiation Oncology. She graduated from Tongji Medical College of Huazhong University of Science and Technology and has published three SCI papers as first author. From July 2019 to July 2022 she completed her standardised residency training in radiation oncology at the Sun Yat-sen University Cancer Centre. She is experienced in the radiotherapy of various malignant tumours, with particular strengths in central nervous system tumours (brain glioma), head and neck tumours (nasopharyngeal carcinoma, oral cancer and others), thoracic tumours (lung cancer, oesophageal cancer, breast cancer, thymoma and thymic carcinoma) and paediatric tumours.
Dr. Zhu Xuan
Attending Physician
Specialty: Radiotherapy for common tumours
A young physician in the Department of Radiation Oncology. She pursued a combined Master's and Doctoral programme in Oncology at Zhejiang University and worked at the First Affiliated Hospital of Zhejiang University School of Medicine from 2019 to 2024. She specialises in the radiotherapy of breast cancer and other thoracic tumours.
Dr. Zhang Zhenyu
Attending Physician
Specialty: Diagnosis and radiotherapy of head and neck tumours such as nasopharyngeal carcinoma, and of various malignant tumours
A young physician in the Department of Radiation Oncology. He holds a Master's degree in Radiation Oncology from Guangzhou Medical University and is a member of the Head and Neck Tumour Committee of the Guangzhou Anti-Cancer Association and of the Tumour Quality and Safety Branch of the Guangdong Medical Safety Association. He has focused on the field of tumour radiotherapy for many years and has published several professional articles in authoritative domestic and international journals. He specialises in the diagnosis, treatment and radiotherapy of head and neck tumours such as nasopharyngeal carcinoma and of various malignant tumours. Drawing on years of clinical experience, he applies advanced radiotherapy techniques with precision — including three-dimensional conformal radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic radiotherapy (Gamma Knife) and proton therapy — and formulates precise radiotherapy plans tailored to each patient's individual condition.
Dr. Luo Yingshan
Attending Physician
Specialty: Radiotherapy for digestive tract tumours such as colorectal and gastric cancer, and for gynaecological tumours such as cervical and vaginal cancer
A young physician in the Department of Radiation Oncology. She holds a Master's degree in Oncology from Southern Medical University. From 2016 to 2019 she completed three years of standardised residency training in radiation oncology at the Sun Yat-sen University Cancer Centre, and from 2019 to 2020 she undertook further training in pelvic tumour radiotherapy at the same centre. She has participated in the publication of four SCI papers and specialises in the radiotherapy of digestive tract tumours such as colorectal and gastric cancer, and of gynaecological tumours such as cervical and vaginal cancer.
Dr. Zhu Lingqun
Associate Chief Physician
Specialty: Radiotherapy for head and neck tumours, central nervous system tumours and paediatric tumours
She holds a PhD in Oncology from Southern Medical University and has been engaged in clinical work for nearly ten years. She completed three years of standardised training in radiation oncology at the Sun Yat-sen University Cancer Hospital, graduating with distinction, and one year of transfer training at the Guangzhou Women and Children's Medical Centre. She has participated in two projects funded by the National Natural Science Foundation of China and one provincial natural science foundation project, and has led one provincial research project. She has published numerous articles in domestic and international journals and is experienced in the radiotherapy of various malignant tumours, with particular strengths in the diagnosis and radiotherapy of head and neck tumours, central nervous system tumours and paediatric tumours. She serves as a committee member and deputy secretary-general of the Tumour Radiotherapy Committee of the Guangdong Organ Medicine and Technology Society, a committee member of the Ion Radiotherapy Branch of the China Association of Medical Equipment, a young committee member of the Nasopharyngeal Carcinoma Committee of the Guangdong Anti-Cancer Association, a committee member of the Guangzhou Physicians' Radiation Oncology Branch, and a committee member of the Head and Neck Tumour Committee of the Guangzhou Anti-Cancer Association.
Dr. Zheng Yuanshui
Professor · Director of the Medical Physics Group, Department of Radiation Oncology
Specialty: Proton therapy technology, adaptive therapy and image-guided therapy
He holds a PhD in Nuclear Engineering from North Carolina State University and completed postdoctoral training at MD Anderson Cancer Center. He is a certified medical physicist of the American College of Radiology, a standing committee member of the AAPM Particle Therapy Committee, and co-editor-in-chief of the Journal of Radiology and Oncology. He is a standing committee member of the Tumour Particle Therapy and Technology Committee of the China Association for Medical Devices Industry and a distinguished talent of Huangpu District, Guangzhou Development District. He has been engaged in radiation applications, clinical practice and research for more than 20 years and has previously served as chief physicist of the Atlanta Medical Group in the United States, associate professor at Oklahoma State University, physics director of the ProCure Proton Therapy Center, and research director of the Breast Centre at the University of North Carolina. He specialises in proton therapy, intensity-modulated and stereotactic radiotherapy, and adaptive therapy, including the development, application and quality control of new technologies. He has published more than 200 books, articles and abstracts in China and abroad.
Dr. Li Zuofeng
Professor, Doctoral Supervisor · Medical Physics Consultant
Specialty: Formulating radiotherapy plans for all types of tumours
He is a Fellow of the American Association of Physicists in Medicine and chief proton physicist of Concord Medical Group. He has worked in radiation physics for more than 30 years, including over 15 years in proton radiotherapy physics. He is an adjunct professor at the University of Science and Technology of China, and formerly a professor in the Department of Radiation Oncology at the University of Florida and physics director of the University of Florida Proton Therapy Institute. He currently serves as co-chair of the Image Guidance Committee of the Particle Therapy Co-Operative Group (PTCOG) and as a member of the Ion Radiotherapy Committee of the American Association of Physicists in Medicine, and has participated in formulating multiple radiotherapy standards for the association. He has served as principal physics investigator for several clinical radiotherapy trials in the United States.
Dr. Liu Qiyong
Associate Chief Physician
Specialty: Tumour radiotherapy
He formerly served as deputy director of the Head Gamma Knife Centre of the Department of Radiation Oncology at the Air Force General Hospital of the Chinese People's Liberation Army and as a Gamma Knife expert at Hebei Yizhou Cancer Hospital. He is a committee member of the Precision Radiotherapy Technology Branch of the Chinese Society of Biomedical Engineering and a committee member of the Radiosurgery Expert Committee of the World Federation of Chinese Neurosurgists. He is one of the physicians in China who began working in the field of radiosurgery at an early stage. Over the years he has treated nearly 10,000 patients with craniocerebral diseases from China and abroad. He specialises in Gamma Knife staged treatment of large intracranial tumours and in the treatment of conditions such as trigeminal and glossopharyngeal neuralgia.
Dr. Li Juan
Chief Physician
Specialty: Precision radiotherapy and comprehensive treatment of head and neck tumours, neuro-oncological tumours and paediatric tumours
A well-known radiotherapy expert, she holds a PhD in Clinical Medicine and is a chief physician. She currently serves as a standing committee member of the Radiotherapy Branch of the Guangdong Medical Doctor Association, a standing committee member of the Radiotherapy Physician Branch of the Guangdong Clinical Doctors Association, a committee member of the Paediatric Tumour Committee of the Guangdong Anti-Cancer Association, a committee member of the Nasopharyngeal Carcinoma Committee of the Guangdong Anti-Cancer Association, a committee member of the Precision Treatment Branch of the Guangdong Medical Association, and a standing committee member of the Young Committee of the Neuro-oncology Committee of the Guangdong Anti-Cancer Association, among other positions. She has 17 years of clinical experience in tertiary hospitals in the fields of neuro-oncological and paediatric tumour radiotherapy, and focuses on precision radiotherapy for neuro-oncological and paediatric tumours — medulloblastoma, glioma, NGGCTs and others — as well as precision radiotherapy for head and neck tumours, the prevention and treatment of radiation necrosis, comprehensive management of angiogenesis-targeted therapy, and multidisciplinary (MDT) diagnosis and treatment.
Dr. Yuan Taize
Chief Physician, Master's Supervisor · Director of the Proton Centre and Director of the Department of Radiation Oncology
Specialty: Radiotherapy for all types of tumours
A well-known radiotherapy expert, he holds a PhD in Oncology from Sun Yat-sen University. He is a council member of the Second Youth Council of the Chinese Anti-Cancer Association, chairman of the Tumour Radiotherapy Committee of the Guangdong Organ Medicine and Technology Society, deputy chairman of the Tumour Medicine Management Branch of the Guangdong Medical Industry Association, deputy chairman of the Radiation Oncology Branch of the Guangzhou Physicians Association, a standing committee member of the Ion Radiotherapy Branch of the China Association of Medical Equipment, and a committee member of the Tumour Particle Therapy Committee of the Chinese Anti-Cancer Association. He has been engaged in tumour radiotherapy for 20 years and formerly served as deputy director of the Department of Radiation Oncology at the Affiliated Cancer Hospital of Guangzhou Medical University. He is familiar with the radiotherapy and comprehensive treatment of various malignant solid tumours, and specialises in three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy (SBRT/SRS) and image-guided radiotherapy (IGRT) for head and neck malignancies such as nasopharyngeal carcinoma, central nervous system malignancies, breast cancer, lung cancer and colorectal cancer. From 2015 to 2016 he was a visiting scholar at the University of Iowa Cancer Centre and the Florida Proton Therapy Institute, and from November 2019 to May 2020 he received proton therapy training at the Mayo Clinic in the United States. He is familiar with proton therapy technology, workflow, indications and quality control.
Dr. Liu Xiaoqing
Chief Physician
Specialty: Diagnosis and treatment of benign and malignant tumours
A well-known radiotherapy expert, she holds a Master's degree in Oncology from Sun Yat-sen University and has been engaged in tumour radiotherapy and chemotherapy for more than 30 years. She is a standing committee member and secretary-general of the Tumour Medicine Management Branch of the Medical Industry Association, a standing committee member and secretary-general of the Radiotherapy Committee of the Organ Medicine and Technology Society, a committee member of the Ion Radiotherapy Branch of the Medical Equipment Association, and a committee member of the Guangdong Colorectal Cancer Committee. With nearly 30 years of experience in tumour radiotherapy and chemotherapy, she specialises in the radiotherapy of various malignant tumours — including nasopharyngeal carcinoma, head and neck tumours, lung cancer, oesophageal cancer, breast cancer, rectal cancer, cervical cancer, prostate cancer, lymphoma and soft tissue sarcoma — as well as chemotherapy, targeted therapy and immunotherapy, and has extensive clinical experience. She is proficient in advanced radiotherapy techniques including proton radiotherapy, IMRT, VMAT, IGRT, SBRT and image-guided painless brachytherapy.
Dr. Fu Shen
Professor, Chief Physician, Doctoral Supervisor · Vice President and Director of the Group Proton Research Centre
Specialty: Tumour radiotherapy and comprehensive diagnosis and treatment
A well-known radiotherapy expert, he holds a PhD in Radiation Oncology. He is the chief scientist of a National Key Research and Development Programme project on proton and heavy ion therapy and the chief expert of the Guangzhou Municipal Health Commission's Proton Characteristic Technology project for 2023 to 2025. He is deputy chairman of the Ion Radiotherapy Branch of the China Association of Medical Equipment. He worked and studied for many years at MD Anderson Cancer Center of the University of Texas, the oncology centre of the Johns Hopkins University Hospital, and Fox Chase Cancer Center in the United States. He has been engaged in tumour radiotherapy, especially the clinical application of proton and heavy ion therapy, and in comprehensive tumour treatment for more than 30 years. Since 2007 he has helped advance the Shanghai proton and heavy ion project, and has served as director of the Department of Radiation Oncology at Shanghai Proton and Heavy Ion Hospital and deputy director of the Radiotherapy Centre at Fudan University Shanghai Cancer Center, assisting the NMPA in formulating multiple clinical management standards and technical guidance principles related to proton and heavy ion therapy.
Dr. Xia Yunfei
Professor at Sun Yat-sen University, Chief Physician, Doctoral Supervisor · Distinguished Radiotherapy Expert
Specialty: Radiotherapy for nasopharyngeal carcinoma, neuro-oncological tumours and lymphoma
A well-known radiotherapy expert, he graduated with a Master's degree in Oncology from Sun Yat-sen University of Medical Sciences in 1994 and has been engaged in tumour radiotherapy for nearly 30 years. In 1999 he was a visiting scholar in the Department of Radiation Oncology at MD Anderson Cancer Center in the United States. He was among the first to propose four types of clinical biological behaviour for nasopharyngeal carcinoma and to use them to guide clinical treatment; he carried out adjuvant radiotherapy with different radiation doses for stage I and II diffuse large B-cell lymphoma; and he proposed improvements to the biological target volume for post-operative radiotherapy of glioma, raising the local control rate for grade I and grade II glioma and improving the quality of life of patients with grade III and grade IV glioma.
Dr. Qian Chaonan
Professor at Sun Yat-sen University, Doctoral Supervisor · President of Guangzhou Concord Cancer Center
Specialty: Diagnosis and treatment of nasopharyngeal carcinoma
He formerly served as vice president of the Sun Yat-sen University Cancer Centre and as academic leader of the State Key Laboratory of Oncology in South China. He obtained his medical doctorate from Sun Yat-sen University of Medical Sciences in 1999. From 2000 to 2003 he received postdoctoral training at MD Anderson Cancer Center of the University of Texas and at the Van Andel Research Institute (VARI) in Michigan, United States. He was an expert for the Ministry of Health's Healthy China 2020 strategic planning research in 2008, and was named among the world's top 100,000 scientists in 2022. He is an associate editor of Cancer Communications and currently serves as vice chairman of the CSCO Vascular Targeted Therapy Expert Committee and chairman of the Tumour Microenvironment Committee of the Chinese Anti-Cancer Association.
Multidisciplinary Planning Behind Every Treatment
Radiotherapy plans at GCCC are not produced in isolation. Radiation oncologists, medical physicists and dosimetrists work together to design and verify each plan, and complex cases are reviewed by the hospital's multidisciplinary (MDT) tumour board, which brings together radiation oncology, medical oncology, surgical oncology, radiology and pathology.
For international patients, the hospital's international medical services team assists with medical record review, remote consultation, visa invitation letters, airport transfers and interpretation, so that treatment can begin promptly after arrival in Guangzhou.